article thumbnail

Community Integration: Pushing the Boundaries for a Better World

Integrated Care News by CFHA

Engage, Empower, Encourage On a recent webinar hosted by ZERO TO THREE HealthySteps , Dr. Omolara Thomas offered the following recommendations to advocate for the communities we serve: Engage patients in non-targeted ways, asking the same questions to all patients, to gauge how government policies are impacting them.

Community 390
article thumbnail

Behind the stethoscope: A conversation with Dr. Osman Saleem

Sound Physicians

I went to the University of Toronto and finished my Bachelor of Science there in 2013. In the back of my mind, I held the image of a once-prestigious Sound hospitalist program and the positive relationship once held with hospital administration. It was my job to work back to that program and gain that respect back.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CONTINUED AGAIN: DEA Announces A Second Extension of its “Temporary Rule” Addressing Telemedicine Flexibilities After the End of the COVID-19 Pandemic Emergency

FDA Law

HPM also conducted a 90-minute webinar addressing the “End of the COVID-19 Emergency and the Ryan Haight Act: Telemedicine and Next Steps.” That First Temporary Rule also provided a one-year grace period, through November 11, 2024, for any practitioner-patient telemedicine relationships established on or before November 11, 2023.

article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

FDA Law

180 days past May 11, 2023) for those telemedicine relationships established during the COVID-19 emergency. within 30 days) in the doctor-patient relationship. We will release exciting details of our upcoming webinar addressing telemedicine soon. Stay tuned.

article thumbnail

CDRH Looks Towards the End of the Public Health Emergency and Transition for EUA and Devices Marketed Under Enforcement Discretion

FDA Law

We urge FDA to clarify the relationship of this policy and the proposed transition plan in the final guidance. The draft guidance proposes a 180-day transition period from the implantation date (the “Transition Period”) for devices marketed under the enforcement discretion policies identified specifically in the draft guidance.

article thumbnail

The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments

FDA Law

Torrente, explained in a previous post , in-person meetings create important opportunities for building rapport, and lead to more robust dialogue and collegial relationships between the Agency and sponsors. requesting records in lieu of an inspection, use of information shared by trusted foreign regulatory partners).

article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine. “You want someone who can monitor patients’ side effects and have a longitudinal relationship with them.” That’s according to two internists who work closely with hospitalized patients who take GLP-1s.